1,250 Manufacturing Sites Inspected Under Risk Based Framework
Mumbai, February 23: The Central Drugs Standard Control Organisation has completed audits of more than 90 per cent of cough syrup manufacturers across the country, as part of an intensified quality compliance drive. A senior official said the regulator expects to resolve existing manufacturing concerns by the next production season.Speaking at the 11th Global Pharmaceutical Quality Summit in Mumbai, Drugs Controller General of India Sanjiv Singh Raghuvanshi confirmed that the inspections covered nearly the entire segment of cough syrup producers operating in India.1,300 Manufacturers Identified, Majority Audited
According to Raghuvanshi, there are over 1,300...